In diabetes with comorbid depression, EE alleviated depressive-like behavior, improved glucose regulation, reduced neuronal apoptosis, and suppressed microglial NLRP3 alongside PI3K/AKT pathway restoration, a negative regulator of inflammasome activation (94). This evidence concerns the gene NLRP3 and depressive symptom measurement.